Schrodinger Inc

SDGR

Equity

ISIN null / Valor 51947209

NASDAQ (2026-09-29)

USD 30.33+2.81%

Schrodinger Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Schrödinger, Inc. (Nasdaq: SDGR) develops and sells a physics‑based computational platform that combines molecular simulation, quantum chemistry and machine‑learning tools to support drug discovery and materials design. Its software and cloud services enable tasks such as molecular docking, structure modeling and refinement, quantum‑mechanical calculations and free‑energy estimation to help researchers prioritize and optimize compounds, and the company supplements software licensing with collaboration, contract research and other services for pharmaceutical, biotechnology and materials customers. In parallel, Schrödinger advances internal drug discovery programs and negotiates partnerships or out‑licensing deals for clinical candidates, generating a mix of recurring software revenue and project‑based income while positioning its tools as a computational complement to laboratory research.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

51.3%1Y

7.29%3Y

-44.5%5Y

Performance

54.2%1Y

59.5%3Y

63.5%5Y

Volatility